Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) open the trading on Wednesday, with a bit cautious approach as it glided -3.62% to $3.46, before settling in for the price of $3.59 at the close. Taking a more long-term approach, MRVI posted a 52-week range of $1.66-$6.21.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -64.27%. Meanwhile, its Annual Earning per share during the time was -64.27%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -213.79%. This publicly-traded company’s shares outstanding now amounts to $144.72 million, simultaneously with a float of $105.64 million. The organization now has a market capitalization sitting at $884.75 million. At the time of writing, stock’s 50-day Moving Average stood at $3.39, while the 200-day Moving Average is $2.63.
Maravai LifeSciences Holdings Inc (MRVI) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Maravai LifeSciences Holdings Inc’s current insider ownership accounts for 27.16%, in contrast to 78.15% institutional ownership. According to the most recent insider trade that took place on Dec 05 ’25, this organization’s Director bought 51,472 shares at the rate of 3.70, making the entire transaction reach 190,446 in total value, affecting insider ownership by 106,595. Preceding that transaction, on Dec 08 ’25, Company’s Director bought 48,528 for 3.67, making the whole transaction’s value amount to 178,098. This particular insider is now the holder of 155,123 in total.
Maravai LifeSciences Holdings Inc (MRVI) Earnings and Revenue Records
Maravai LifeSciences Holdings Inc’s EPS decrease for this current 12-month fiscal period is -213.79% and is forecasted to reach -0.21 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -16.72% through the next 5 years, which can be compared against the -64.27% growth it accomplished over the previous five years trading on the market.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Trading Performance Indicators
Let’s observe the current performance indicators for Maravai LifeSciences Holdings Inc (MRVI). It’s Quick Ratio in the last reported quarter now stands at 4.56. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.60.
In the same vein, MRVI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.84, a figure that is expected to reach -0.07 in the next quarter, and analysts are predicting that it will be -0.21 at the market close of one year from today.
Technical Analysis of Maravai LifeSciences Holdings Inc (MRVI)
[Maravai LifeSciences Holdings Inc, MRVI] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 25.34% While, its Average True Range was 42.36.
Raw Stochastic average of Maravai LifeSciences Holdings Inc (MRVI) in the period of the previous 100 days is set at 75.00%, which indicates a major rise in contrast to 22.83% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.18 that was lower than 0.19 volatility it exhibited in the past 100-days period.
